Unichem Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹640 crore and net profit of ₹22 crore for the September 2026 quarter.
Unichem Laboratories (NSE: UNICHEMLAB) closed at ₹468.95 on 20 Nov 2026, down 1.9% over the past year. Its market capitalisation is ₹3,302 crore and it trades at 27.8 times earnings.
Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.